Prescription Drug User Fee Act (PDUFA) Target Action Date of March 25, 2022EMERYVILLE, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) --…
Dr. Colin brings four decades of clinical experience in pediatric pulmonology to Beyond Air, with research spanning respiratory physiology, Cystic…
NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company…
Company to host virtual investor event on Sunday, December 12, 2021 at 11:00 a.m. ETSOUTH SAN FRANCISCO, Calif., Dec. 01,…
NEW YORK, NY, Dec. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”),…
Former Chief Medical Officer of Juno Therapeutics Brings Decades of Oncology Clinical Development ExpertiseNEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE)…
Renowned Expert Dr. Christopher Gauland Shares Insights on Treating DFUs and Success with AC5® Advanced Wound System FRAMINGHAM, Mass., Dec.…
LSALT Peptide (LSALT) is a novel drug candidate that targets acute organ inflammation in the lungs, liver and kidneys which…
Modifications to Entolimod clinical trial protocol in acute radiation syndrome enable continued program developmentFORT COLLINS, Colo., Dec. 01, 2021 (GLOBE…
ATLANTA, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is…